Ireland
--:--IST
Latest
Clinical Trials in Italy / NCT06552078
Recruiting Observational

Activation of Biobank Registry for Bilio-pancreatic Diseases

NCT06552078 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2021-06-09
Last updated
2026-09-08

Condition(s) studied

PancreatitisPancreatic DiseaseNon-Neoplastic Pancreatic DisorderPancreatic Adenocarcinoma

Study summary

The purpose of establishing the biobank is to create a collection of biological material and clinical data, with a prospective and retrospective mold, in order to investigate the role of genetic predisposition in multifactorial bilio-pancreatic diseases, so that an evaluation of the possible association in the pathogenesis of exogenous factors with endogenous factors can be allowed.

Multifactorial diseases are in fact an expression of genetic predisposition upon which one or more environmental stimuli act. Usually the aforementioned factors are not capable individually of triggering disease but, when simultaneously present, can cause the pathological phenotype. Therefore, it becomes important in the description of disease pathogenesis to identify as many risk factors for disease prevention and early diagnosis.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * age \>= 18 years * signed informed consent Exclusion Criteria: * age \< 18 years * unwilling to sign informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
IRCCS OSpedale San Raffaele Milan Italy Recruiting

More IRCCS San Raffaele trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06552078 on ClinicalTrials.gov ↗ ← All trials in Italy